Tevogen Bio Holdings Inc.
TVGN
Rank in Stocks
#25688
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology firm dedicated to... Tevogen Bio Holdings Inc. is a clinical-stage biotechnology firm dedicated to developing "off-the-shelf" precision T cell therapies for conditions across virology, oncology, and neurology. Its flagship experimental product, TVGN 489, is a precision T cell therapeutic engineered to address critical unmet needs in patients with acute-risk COVID-19, alongside a specific population experiencing long COVID. The company's operations are headquartered in Warren, New Jersey.
Share Price
$5.84
Last synced: 2026-11-09
Market Cap
$24.32M
Change (1 day)
4.47%
Change (1 year)
-74.92%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Tevogen Bio Holdings Inc. (TVGN)
Category
Healthcare
EPS for Tevogen Bio Holdings Inc. (TVGN)
EPS as of June 2026 TTM: $-5.83
According to Tevogen Bio Holdings Inc.'s latest financial reports, its current EPS (TTM) is $-5.83. At the end of 2025 the company had an EPS of $-8.08, a decrease compared to its 2024 EPS of $-4.68.
EPS history for Tevogen Bio Holdings Inc. from 2021 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-5.83 | -27.85% |
| 2025 | $-8.08 | 72.65% |
| 2024 | $-4.68 | 23,300.00% |
| 2023 | $-0.02 | -101.09% |
| 2022 | $1.84 | -111.12% |
| 2021 | $-16.50 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -368.61% |
US
|
|
| $-7.07 | 21.27% |
US
|
|
| $-5.29 | -9.26% |
AU
|
|
| $12.88 | -320.93% |
BE
|
|
| $21.56 | -469.81% |
NL
|
Questions about Tevogen Bio Holdings Inc.'s earnings per share (EPS)
What is Tevogen Bio Holdings Inc.'s earnings per share (EPS)?
Tevogen Bio Holdings Inc.'s earnings per share (EPS) over the last twelve months is $-5.83, as of Jun 2026.
What was Tevogen Bio Holdings Inc.'s earnings per share (EPS) in 2025?
In 2025, Tevogen Bio Holdings Inc.'s earnings per share (EPS) was $-8.08, compared with $-4.68 in 2024.
How has Tevogen Bio Holdings Inc.'s earnings per share (EPS) changed since 2021?
From 2021 to 2025, Tevogen Bio Holdings Inc.'s earnings per share (EPS) was highest in 2022 ($1.84) and lowest in 2021 ($-16.50).
How does Tevogen Bio Holdings Inc.'s earnings per share (EPS) compare with similar companies?
Tevogen Bio Holdings Inc.'s earnings per share (EPS) ($-5.83) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.